- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- July 2026
- 373 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 282 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 275 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 275 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 454 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- May 2026
- 146 Pages
Global
From €3581EUR$3,950USD£3,051GBP
- Report
- May 2026
- 145 Pages
Global
From €3581EUR$3,950USD£3,051GBP
- Report
- May 2026
- 153 Pages
Global
From €3581EUR$3,950USD£3,051GBP
- Report
- May 2026
- 157 Pages
Global
From €3581EUR$3,950USD£3,051GBP
- Report
- October 2025
- 160 Pages
Global
From €2864EUR$3,160USD£2,440GBP
€3581EUR$3,950USD£3,051GBP
- Report
- December 2025
- 135 Pages
Global
From €4396EUR$4,850USD£3,746GBP
- Report
- September 2025
- 150 Pages
Global
From €4396EUR$4,850USD£3,746GBP

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more